Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,356.00
Bid: 12,390.00
Ask: 12,394.00
Change: 28.00 (0.23%)
Spread: 4.00 (0.032%)
Open: 12,364.00
High: 12,454.00
Low: 12,322.00
Prev. Close: 12,328.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-London's FTSE 100 drops to near one-month low as lockdown fears weigh

Thu, 28th Jan 2021 09:24

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* UK demands AstraZeneca to deliver ordered vaccines

* Car output falls to lowest level since 1984

* Prudential drops on demerger and equity raise plans

* FTSE 100 falls 0.6%, FTSE 250 adds 0.4%
(Updates to close)

By Shashank Nayar and Amal S

Jan 28 (Reuters) - The FTSE 100 hit a near one-month
low on Thursday as energy stocks tracked commodity prices lower
following virus and lockdown-led demand worries, while the
vaccine row between the European Union and AstraZeneca Plc
continued to weigh.

AstraZeneca was the second biggest drag on the FTSE
100 index as Britain demanded it must receive all the COVID-19
vaccines it had ordered, while the EU warned drug companies that
it would use all legal means or even block exports unless they
agreed to deliver shots as promised.

The blue-chip FTSE 100 index fell 0.6% with insurer
Prudential being the top drag after it said it would
separate its U.S. business Jackson through a demerger and may
raise $2.5 billion to $3 billion in new equity.

"It's a very speculative bubble of a market that has
definitely led to people suggesting for a pullback," said Keith
Temperton, an equity sales trader at Forte Securities.

"So, in my view, it's a long overdue pullback and nothing to
be alarmed about particularly, but rather just an expected
market reaction for London."

Higher virus cases and lockdowns led the UK to its biggest
rise in vacant shops in over two decades, while car output fell
to its lowest level since 1984.

The export-heavy FTSE 100 has recorded consistent monthly
gains since Novemeber, but recently lost steam as rising cases
and lockdowns led British households to cut expenses while the
proportion of workers on furlough rose to its highest since
July.

British airline easyJet gained 4.6% even as it warned that
its prospect had worsened for the January-March quarter.
London-listed shares of Hungarian airline Wizz Air
jumped 4.7% after it vowed to use the coronavirus crisis to grab
business from rivals including easyJet.

Miner Anglo American slipped 3.9% after it trimmed
its 2021 production outlook for diamonds, but it kept output
targets for most other metals unchanged.
(Reporting by Shashank Nayar in Bengaluru; editing by
Uttaresh.V and Richard Chang)

More News
19 Jun 2023 06:55

LONDON MARKET EARLY CALL: Stocks to fall but pound rises ahead of BoE

(Alliance News) - Stocks in London are set to open lower on Monday, with a Bank of England decision ahead, and as developments in US-China relations are also in focus.

Read more
16 Jun 2023 12:59

Sell GBP on aggressive BoE pricing - Danske Bank

STOXX 600 up 0.6%

*

Read more
15 Jun 2023 17:02

LONDON MARKET CLOSE: Europe mixed after ECB hike and hawkish Fed

(Alliance News) - London's FTSE 100 closed higher, though equities in mainland Europe weakened, after both the Federal Reserve and European Central Bank both hinted that they are not done with rate hikes.

Read more
13 Jun 2023 08:41

AstraZeneca wins approval in China for Soliris in myasthenia gravis

(Alliance News) - AstraZeneca PLC on Tuesday announced another approval in China for Soliris to treat a rare neuromuscular disease.

Read more
12 Jun 2023 13:08

Novartis buys Chinook for $3.5 bln in race to treat rare kidney disease

June 12 (Reuters) - Novartis said it has agreed to acquire U.S. biotech firm Chinook Therapeutics for up to $3.5 billion to boost its late-stage drug development line-up, raising the stakes in the race for a rare kidney disease treatment.

Read more
12 Jun 2023 08:39

AstraZeneca breast cancer drug capivasertib gets priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its breast cancer drug capivasertib in combination with breast-cancer treating hormone therapy drug faslodex has been granted priority review in the US for patients with advanced HR-positive breast cancer.

Read more
9 Jun 2023 10:09

AstraZeneca gets new FDA RSV approval, partners with Quell

(Sharecast News) - AstraZeneca announced on Friday that the US Food and Drug Administration (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) had unanimously voted in favour of 'nirsevimab' as a preventive treatment for respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns and infants.

Read more
9 Jun 2023 09:11

TOP NEWS: AstraZeneca hails deal with Quell; positive danicopan data

(Alliance News) - AstraZeneca PLC on Friday reported positive phase 3 trial data for its oral drug danicopan and struck an agreement with London-based biopharma company Quell Therapeutics Ltd.

Read more
9 Jun 2023 07:55

LONDON BRIEFING: Network International agrees to GBP2.2 billion buyout

(Alliance News) - Stocks in London were called to open higher on Friday, after a weak US jobless claims reading threw "cold water" over expectations for an interest rate hike by the Federal Reserve next week.

Read more
9 Jun 2023 06:53

AstraZeneca hails RSV drug nirsevimab recommendation by FDA committee

(Alliance News) - AstraZeneca PLC on Thursday said that a US Food & Drug Administration committee unanimously recommended its antibody nirsevimab.

Read more
5 Jun 2023 17:17

London stocks slip as global growth concerns weigh

Indivior jumps on U.S. Suboxone lawsuit settlement

*

Read more
5 Jun 2023 16:59

AstraZeneca and Daiichi Sankyo report progress in cancer drug trials

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday reported positive results from trials of two cancer drugs, Enhertu and datopotamab deruxtecan.

Read more
5 Jun 2023 09:48

AstraZeneca stops Andexxa trial early, Tagrisso reduces death risk

(Alliance News) - AstraZeneca PLC on Monday said its Andexxa phase four trial will be stopped early after achieving positive efficacy data.

Read more
2 Jun 2023 18:04

AstraZeneca sees positive results for Imfinzi in gastric cancers

(Alliance News) - AstraZeneca PLC on Friday reported positive results from planned interim analysis of a phase three trial evaluating its Imfinzi drug in gastric and gastroesophageal junction cancers.

Read more
1 Jun 2023 08:07

TOP NEWS: AstraZeneca discontinues brazikumab; Lynparza wins approval

(Alliance News) - AstraZeneca PLC on Thursday hailed another approval for cancer drug Lynparza, while it ceased its development programme for Crohn's disease-focused brazikumab.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.